Navigation Links
MRSA policies differ among hospitals, study shows
Date:8/17/2010

Hospitals vary in how they detect and treat drug-resistant staph infections, but most follow national guideline recommendations, according to researchers at the University of Illinois at Chicago.

Researchers sent a 61-item questionnaire to pharmacy directors at 263 acute-care hospitals in the U.S. to learn of their policies and practices regarding methicillin-resistant Staphylococcus aureus, or MRSA. All of the hospitals are members of Broadlane, a health care cost management company based in Dallas.

Among the 102 hospitals that responded, 43 percent said they had a procedure to screen patients for MRSA, a strain of staph bacteria that has become resistant to the antibiotics commonly used to treat ordinary staph infections, says Yoojung Yang, a fellow in the Center for Pharmacoeconomic Research who led the study.

MRSA is a leading cause of health care-acquired infections in hospitals or other health care settings, such as nursing homes and dialysis centers.

Staph is commonly found on skin and other body surfaces. Most of the time, the bacteria cause no harmful effects. Staph becomes a problem when the bacteria invade the system. MRSA can spread through direct contact with an infected person or by sharing personal items that have touched infected skin.

Prevention is the best treatment for MRSA. Nearly all of the hospitals surveyed have adopted hand-hygiene practices, Yang said. Other preventive practices include the use of gowns and gloves, and isolation of MRSA-positive patients, she said.

Nearly 75 percent of the responding hospitals review antimicrobial prescription orders and place restrictions on the use of select antimicrobials in an effort to ensure optimal use of the drugs and to reduce the risk of bacterial resistance, Yang said.

"The results of our survey suggest that pharmacists play a key role in the treatment of MRSA infections, because they have the knowledge of how best antimicrobials can be used," she said.

Vancomycin, the traditional drug of choice, was on the formulary in all of the hospitals, and only three hospitals had restrictions placed on its use, Yang said. Newer drugs such as linezolid, daptomycin and tigecycline were on the formulary in the vast majority of the respondent hospitals. Restrictions of their use were reported by more than half.

According to Glen Schumock, professor and director of the Center for Pharmacoeconomic Research who assisted Yang, this is the first survey of hospital pharmacy directors to address comprehensive MRSA treatment options. The results, he said, could identify areas for potential improvement in the prevention and management of the potentially deadly pathogen.


'/>"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
Source:Eurekalert

Related medicine news :

1. New study examines the economic returns of public access policies
2. ICRW Says to Stop Violence against Women, Aim National Policies at Men
3. Mathematical model can help communities better evaluate sex offender policies
4. Kidney Patients From Across South Carolina Visit State Capitol to Encourage Policies that Improve Patient Access to Life-Saving Dialysis and Transplant Care
5. Comments by American Dental Association President Dr. Ron Tankersley on the Pew Center on the States report The Cost of Delay: State Dental Policies Fail One in Five Children
6. Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care
7. Scientists map epigenetic changes during blood cell differentiation
8. Breast cancer risk varies among different progestins used in hormone replacement therapy
9. Chemical system in brain behaves differently in cocaine addicts, UT Southwestern scientists find
10. Not all kidney patients treated equal: Differences in care for patients beginning on dialysis
11. Effective inducing systems of hepatic differentiation from bone marrow mesenchymal stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... MN (PRWEB) , ... March 24, 2017 , ... ... back to the military at the same time by providing Prehospital Trauma Life ... Guard. PHTLS is the world’s premier prehospital trauma education developed in cooperation with ...
(Date:3/24/2017)... ... 24, 2017 , ... According to a new study by NCPA Senior Fellow ... obey the rules Congress has directed the CBO to follow. The CBO itself previously ... restore. Yet, it estimates a reduction in employer-based coverage due to the GOP reform, ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on Kickstarter ... demand for the product – with nearly 2,000 consumers (and counting) already backing ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... Viewers who ... variety of critical historical facts, cultural practices, goods, services, and societal issues tend to ... will look into the popular practice of utilizing running events for causes around the ...
(Date:3/24/2017)... ... 24, 2017 , ... “End Time GPS”: a dauntless and enlightened study ... Time GPS” is the creation of published author, Wesley Gerboth, a World War II ... and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... INDIANAPOLIS , March 23, 2017  Eli Lilly ... William Sansum Diabetes Center have established a research collaboration ... diabetes through enhanced research, education and care. ... bears a disproportionate weight on Latino families in ... Kerr , M.D., FRCPE, director of Innovation and Research ...
(Date:3/23/2017)...  The U.S. Food and Drug Administration today granted ... adults and pediatric patients 12 years and older with ... not received prior chemotherapy. This is the first FDA-approved ... skin cancer. "While skin cancer is one ... form called Merkel cell cancer have not had an ...
(Date:3/23/2017)...   BioSpace , the leading biotechnology and pharmaceutical ... Indiana Biosciences Research Institute and over 20 dynamic ... to bring the state,s life sciences industry to the ... artistic representation of the region,s booming biotechnology and pharmaceutical ... Mike Pence , a long-time advocate of the ...
Breaking Medicine Technology: